Kalif Eliyahu Sharon — SEC Form 4 filings
SEC reporting owner CIK 1798443. 17 Form 4 filings on record with FilingPulse; latest filed 2026-06-16.
Transaction summary — filings shown
Covers all 17 filings on record, filed 2024-02-01 to 2026-06-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 6 filings — 794,699 shares, $23,629,437 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 38.
- Largest priced transaction: sale of 345,810 shares @ $33.64 ($11,634,708) in TEVA PHARMACEUTICAL INDUSTRIES LTD, filed 2026-03-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Chief Financial Officer | 17 | — | 6 legs · 794,699 sh · $23,629,437 | 38 |
Form 4 filings — Kalif Eliyahu Sharon
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-16 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 106,563 @ $34.10 | EDGAR |
| 2026-05-18 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 153,251 @ $35.61 | EDGAR |
| 2026-03-09 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 19,916 · Option exercise (M): 19,916 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 33,512 · Option exercise (M): 23,251 · Option exercise (M): 33,512 (derivative) @ $0 · Option exercise (M): 23,251 (derivative) @ $0 · Grant/award (A): 53,175 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 49,800 · Option exercise (M): 141,478 · Option exercise (M): 49,800 (derivative) @ $0 · Option exercise (M): 141,478 (derivative) @ $0 | EDGAR |
| 2026-03-02 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 345,810 @ $33.64 | EDGAR |
| 2026-01-29 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/award (A): 141,478 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 55,775 @ $17.08 | EDGAR |
| 2025-03-07 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 21,390 · Option exercise (M): 21,390 (derivative) @ $0 · Grant/award (A): 79,664 (derivative) @ $0 | EDGAR |
| 2025-03-06 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 33,512 · Option exercise (M): 23,251 · Option exercise (M): 183,169 · Option exercise (M): 33,512 (derivative) @ $0 · Option exercise (M): 23,251 (derivative) @ $0 · Option exercise (M): 183,169 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 55,750 @ $16.21 · Option exercise (M): 49,800 · Option exercise (M): 49,800 (derivative) @ $0 | EDGAR |
| 2025-01-30 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/award (A): 183,169 (derivative) @ $0 | EDGAR |
| 2024-03-07 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 52,320 · Option exercise (M): 21,387 · Sale (S): 77,550 @ $13.52 · Option exercise (M): 21,387 (derivative) @ $0 · Option exercise (M): 52,320 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 49,800 · Option exercise (M): 33,512 · Option exercise (M): 49,800 (derivative) @ $0 · Option exercise (M): 33,512 (derivative) @ $0 · Grant/award (A): 93,005 (derivative) @ $0 | EDGAR |
| 2024-03-01 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 18,430 · Option exercise (M): 18,430 (derivative) @ $0 | EDGAR |
| 2024-02-15 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 6,630 · Option exercise (M): 6,630 (derivative) @ $0 | EDGAR |
| 2024-02-01 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/award (A): 52,320 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1798443 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →